Under the terms of the agreement, Beihai Biotech will be responsible for the manufacturing and supply of the product while Zydus will be responsible for commercialisation of the product in the US, it ...
The inspection was conducted from February 10th to 14th, 2025. The inspection concluded with NIL observations," Zydus Lifesciences said in a regulatory filing. Zydus Lifesciences' US formulation sales ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Under the terms of this agreement, Beihai Biotech will be responsible for the manufacturing and supply of the product. Zydus will be responsible for commercialization of the product in the US. Beihai ...
Nippon India Small Cap Fund - Direct (IDCW) 530.87 28,90,897 0.93 Nippon India Small Cap Fund - Direct (G) 530.87 28,90,897 0.93 Nippon India Small Cap Fund - Direct ...
Zydus Wellness Ltd., incorporated in the year 1994, is a Mid Cap company (having a market cap of Rs 10,508.21 Crore) operating in FMCG sector. Zydus Wellness Ltd. key Products/Revenue Segments include ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback